Bioequivalence Study: 2 mg Estradiol Valerate (EV) and 3 mg Dienogest (DNG) Without and With Levomefolate Calcium

NCT00941057 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

43

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacology, Clinical

Interventions

DRUG: BAY 98-7079, Estradiolvalerate (EV) / Dienogest (DNG) / Levomefolate calcium
DRUG: BAY 86-5027,Estradiolvalerate(EV) / Dienogest (DNG)
DRUG: BAY 86-7660,levomefolate calcium

Sponsor

Bayer